Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
Multiple Cancer Types
Clinical study to investigate the efficacy and safety of savolitinib in combination with
osimertinib versus platinum-based doublet chemotherapy in participants with EGFR mutated,
MET-overexpressed and/or amplified, locally advanced or metastatic NSCLC who have progressed
on treatment with Osimertinib.
osimertinib versus platinum-based doublet chemotherapy in participants with EGFR mutated,
MET-overexpressed and/or amplified, locally advanced or metastatic NSCLC who have progressed
on treatment with Osimertinib.
Lung,
Non Small Cell
III
Iams, Wade
NCT05261399
VICCTHO2219
Molecular Predictors of Lung Cancer Behavior. (SPORE)
Multiple Cancer Types
Lung,
Non Small Cell,
Small Cell
N/A
Maldonado, Fabien
NCT00898313
VICCTHO0398
Molecular Fingerprinting of Lung Cancer (SPORE)
Multiple Cancer Types
Lung,
Non Small Cell
N/A
Grogan, Eric
NCT00897117
VICCTHO0136
Nashville Biosciences Blood Sample Collection Study
Multiple Cancer Types
Colon,
Liver,
Lung,
Non Small Cell,
Ovarian,
Pancreatic,
Rectal
N/A
Bernard, Gordon
VICCMD18123